1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow SPI-2012: new trials by email Literature Review of SPI-2012 trials Research Report on SPI-2012
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer SPI-2012, Pegfilgrastim, Docetaxel - Neutropenia | Phase 2 | Completed | Spectrum Pharmaceuticals, Inc | 148 | 2013-03-25 | 2022-04-15 |
Neutropenia (1)
Spectrum Pharmaceuticals, Inc (1)
Australia (1) · Georgia (1) · Hungary (1) · Israel (1) · Poland (1) · United States (1)